| AFM | atomic force microscopy |
| API | active pharmaceutical ingredient |
| CH | cholesterol |
| CMAs | Critical Material Attributes |
| CPPs | Critical Process Parameters |
| CQAs | Critical Quality Attributes |
| DLS | dynamic light scattering |
| DoE | Design of Experiments |
| DPPE-PEG2000 | 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) |
| DS | Design Space |
| DSC | differential scanning calorimetry |
| DSPE–PEG2000 | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] (ammonium salt) |
| dTG | derivative thermogravimetry |
| EMA | European Medicine Agency |
| FT-IR | Fourier-transform infrared spectroscopy |
| ICH | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use |
| LUV | large unilamellar vesicles |
| PBS | phosphate-buffered saline |
| PC | L-α-phosphatidylcholine |
| PdI | Polydispersity Index |
| PE | phosphatidylethanolamine |
| PEG | polyethylene glycol |
| QbD | Quality by Design |
| QTPP | Quality Target Product Profile |
| R&D | Research and Development |
| RA | Risk Assessment |
| Tc | gel to liquid-crystalline phase transition temperature |
| Tg | glass transitions temperature |
| TGA | thermogravimetric analysis |
| Tm | phase transition temperature |